Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is a pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products
Orchid Pharma Limited, is a listed public company incorporated on 01 July, 1992. It is classified as a public limited company and is located in , Tamil Nadu. It's authorized share capital is INR 150.00 cr and the total paid-up capital is INR 50.72 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Ram Gopal Agarwal | 00627386 | 5 years |
Whole-time Director | Mridul Dhanuka | 00199441 | 5 years |
Director | Dharam Vir | 08771224 | 5 years |
Director | Tanu Singla | 08774132 | 5 years |
Director | Manoj Kumar Goyal | 06361663 | 5 years |
Managing Director | Manish Dhanuka | 00238798 | 5 years |
Director | Shubha Singh | 06926872 | 1 years |
Director | Arjun Dhanuka | 00454689 | 2 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 2
Total Amount : 291.5 cr
Yes Bank Limited
No. of Loans: 1
Total Amount : 75.0 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Orchid Pharmaceuticals Inc And Subsidiaries, USA | United States Of America | - | - |
Bexel Pharmaceuticals Inc., USA | United States Of America | - | - |
Diakron Pharmaceuticals Inc., USA | United States Of America | - | - |
ORCHID BIO-PHARMA LIMITED | Tamil Nadu | 2022 | ₹ 15.0 Cr |
Orchid Pharmaceuticals Inc., and Subsidiaries, USA | Usa | - | - |
Bexel Pharmaceuticals Inc., USA | Usa | - | - |
Diakron Pharmaceuticals Inc, USA | Usa | - | - |
Read more
The incorporation date of ORCHID PHARMA LIMITED is 01 July, 1992
The authorized share capital of ORCHID PHARMA LIMITED is INR ₹ 150.0 Cr.
The paid-up capital of ORCHID PHARMA LIMITED is INR ₹ 50.7 Cr.
The registered address of ORCHID PHARMA LIMITED is PLOT NO 121-128, 128A-133, 138-151, 159-164, SIDCO INDUSTRIAL ESTATE,ALATHUR,CHENGALPATTU, Alathur Industrial Estate, Kanchipuram, Chengalpattu, Tamil Nadu, India, 603110 - 603110
The CIN number of ORCHID PHARMA LIMITED is L24222TN1992PLC022994.